PIN44 Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis: A Canadian Cost-Utility Analysis
Authors:
- C. BeaucheminCBC. Beauchemin
- K. GuinanKGK. Guinan
- K. MathurinKMK. Mathurin
- S.F. DufresneSDS.F. Dufresne
- C. RotsteinCRC. Rotstein
- D. ClaveauDCD. Claveau
- L. LandryLLL. Landry
- J. LachaineJLJ. Lachaine
- 1 December 2020
- journal article
- Published by Elsevier in Value in Health
- Vol. 23, S551-S552